Newswire FDA Issues Revised Guidance on Drug Delivery Devices November 3, 2026 The FDA has announced a revised draft guidance for industry titled “Essential Drug Delivery Performance…
Newswire Neuralink’s Blindsight Vision Implant Faces Clinical Readiness Questions November 3, 2026 Neuralink’s plans for a brain implant designed to restore vision have gained attention following a…
Newswire Fresenius Expands Biosimilars Pipeline with WuXi Biologics Partnership November 3, 2026 Fresenius is expanding its biosimilars strategy through an exclusive development agreement with WuXi Biologics that…
Newswire Buccal Drug Delivery Market Expected to Grow Significantly November 3, 2026 The global market for buccal drug delivery systems is projected to maintain strong growth through…
Newswire Inovio’s Voceryq Receives FDA Accelerated Approval November 2, 2026 Inovio has secured accelerated approval from the FDA for Voceryq to minimise the frequency of…
Newswire MHRA Promotes Yellow Card Reporting for MedSafetyWeek November 2, 2026 The MHRA is encouraging patients, parents, carers, and healthcare professionals to report suspected side effects…
Newswire Kymera’s eczema trial readout could rival Dupixent November 2, 2026 Kymera Therapeutics is set to announce data from a mid-stage clinical trial of its lead…
Newswire Gene Editing Stocks Surge on FDA Guidance and ESGCT Data November 2, 2026 Shares of gene editing therapy companies surged by double digits recently, driven by two key…
Newswire Opentrons Secures $40M for Robotics and AI Expansion November 1, 2026 Opentrons Labworks has raised $40 million from a Series E financing round led by healthcare…
Newswire Parse and Nomic Create 100 Million-Cell Dataset November 1, 2026 Parse Biosciences, a QIAGEN company, and Nomic Bio have partnered to generate Cascade, a 100…